Please login to the form below
Consideration
This page shows the latest Consideration news and features for those working in and with pharma, biotech and healthcare.
WHO countries hold seventh INB meeting to prevent global pandemics
The proposed amendments from the latest meeting on 7 December are scheduled for consideration and adoption at the next World Health Assembly.
Latest news
-
New report identifies key issues with NICE’s methods for evaluating Alzheimer’s drugs
Alzheimer’s drugs, but has highlighted key issues for consideration.
-
UK antibiotic subscription model found by OHE as key to supporting investment
The recommendations include clarification of long-term commitments to the scheme, considerations of a form of early advice or dialogue for developers and more.
-
AstraZeneca’s Forxiga shows promise in paediatric type 2 diabetes trial
This is an important treatment consideration as children and adolescents with T2D often experience earlier onset of complications and faster advancement of disease compared to adults with the same condition.”.
-
The AI Roadmap – charting our future in healthcare communications
He continued: “The AI Roadmap provides an initial consideration of where and how the sector should start, or continue, to engage with AI.”.
-
Being healthy
Stop and consider that. All the work by countless organisations, individuals and health systems to encourage – alongside physical health – consideration of mental health, social health and the environment in which we
More from news
Approximately 0 fully matching, plus 471 partially matching documents found.
Latest Intelligence
-
Virtual care – negotiating barriers to adoption offers glimpses of an exciting future
But it is still a frontier opportunity riven with regulatory considerations and safety concerns.
-
Pharma AI: how sales and marketing are starting to step out of R&D’s shadow
and that of caution, given that compliance and ethical considerations must be given due weight. ... For the latter firms, considerations of people and processes, as well as the technology will be key.
-
Connected devices: key considerations for pharmaceutical companies
How the use of data from connected drug delivery devices could help transform clinical trials
-
Focusing in on real-world evidence and its capabilities
Several barriers to the use of RWE in the EU require close consideration, including concerns with regard to data privacy and access issues, as well as to relevance, fragmentation, depth and
-
Launch excellence: five critical areas
intelligence, stakeholder mapping and consideration of the hurdles involved.
More from intelligence
Approximately 0 fully matching, plus 184 partially matching documents found.
Latest appointments
-
NDA bolsters its senior team
regulatory and market access considerations to meet their goals.”.
-
EMA’s Pharmacovigilance Risk Assessment Committee gains new members
Its objective is to assess and monitor safety issues for human medicines, giving recommendations for consideration by the Committee for Medicinal Products for Human Use (CHMP). ... The EMA said: “Their role is to bring the views, concerns and
-
Larry Bell joins Dutch biopharma Prosensa
As the orphan drugs space grows in size and scope, there are many regulatory considerations that need to be addressed in order for new drugs to reach the patients that need
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
If this is to be the case, a key consideration will be that while the primary audience for femtech right now is of an age more likely to engage with technology ... Lack of consideration of sex and gender in COVID-19 clinical studies.
-
Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
The ultimate goal of all (completed and planned) projects is to ensure that the needs and preferences of the broader patient population are taken into consideration and that the clinical trial
-
EU Joint Clinical Assessment (JCA) – implications for Pharma and Medtech
Four key considerations for Pharma and Medtech. Manufacturers can expect to face various challenges throughout the JCA process, including:. ... How can Mtech Access provide support? We can help Pharma and Medtech companies with strategic considerations,
-
Clinical trials explained: Why branding matters…
We use this to steer our thinking — from a trial’s purpose, through contextual considerations about what patients need and how they might benefit, to its corresponding ‘personality’:.
-
Multi-award-winning healthcare communications agency fox&cat scoops PR Week’s New Consultancy of the Year 2023
equal consideration to clients’ unique pressures and team welfare using our ADAPT planning framework, and solutions focused business coaching (SFBC).
More from PMHub
Approximately 2 fully matching, plus 131 partially matching documents found.
Subscribe to our email news alerts
- OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis
- FDA approves two cell-based gene therapies for sickle cell disease
- Pfizer’s Elrexfio granted EC approval for relapsed and refractory multiple myeloma
- New economic data reveals risk of disincentivising UK life sciences growth
- WHO countries hold seventh INB meeting to prevent global pandemics
- The start of a beautiful friendship
No results were found
PMHub
AMICULUM
AMICULUM is an independent family of 11 branded agencies that deliver communications and consultancy services to pharmaceutical, biotechnology and health...
Latest intelligence
- Virtual care – negotiating barriers to adoption offers glimpses of an exciting future
- Digital tools and innovative healthcare promise to address pressing healthcare issues if they can satisfy concerns over access, security and affordability...
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
